Leukemia

DR Ibraheem Bashayreh, RN, PhD

8/12/2009 1
Leukemia
 A group of malignant disorders affecting
the blood and blood-forming tissues of
– Bone marrow
– Lymph system
– Spleen
 Occurs in all age groups

8/12/2009 2
Leukemia
 Results in an accumulation of
dysfunctional cells because of a loss of
regulation in cell division
 Fatal if untreated

– Progressive

8/12/2009 3
Leukemia
 Often thought of as a childhood disease
 The number of adults affected with
leukemia is 10 times that of children

8/12/2009 4
Leukemia
Etiology and Pathophysiology
 No single causative agent
 Most from a combination of factors

– Genetic and environmental influences

8/12/2009 5
Leukemia
Etiology and Pathophysiology
 Associated with the development of leukemia
– Chemical agents
– Chemotherapeutic agents
– Viruses
– Radiation
– Immunologic deficiencies

8/12/2009 6
Leukemia
Classification
 Acute versus chronic
– Cell maturity
• Acute: clonal proliferation of immature
hematopoietic cells (the formation of
blood or blood cells )
• Chronic: mature forms of WBC; onset is
more gradual
– Nature of disease onset
8/12/2009 7
Leukemia
Classification
 Type of white blood cell (WBC)
– Acute lymphocytic leukemia (ALL)
– Acute myelogenous leukemia (AML)
• Also called acute nonlymphoblastic
leukemia (ANLL)
– Chronic myelogenous leukemia (CML)
– Chronic lymphocytic leukemia (CLL)
8/12/2009 8
Myelogenous Leukemia
 Leukemia characterized by proliferation
of myeloid tissue (as of the bone marrow
and spleen) and an abnormal increase in
the number of granulocytes, myelocytes,
and myeloblasts in the circulating blood

8/12/2009 9
 Myeloid tissue is a biologic tissue with the
ability to perform hematopoiesis. It is mainly
found as the red bone marrow in bones, and is
often synonymous with this. However, myeloid
can also be present in the liver and spleen .
 A myelocyte is a young cell of the granulocytic
series, occurring normally in bone marrow, but
not in circulating blood (except when caused by
certain diseases).

8/12/2009 10
  Granulocytes are a category of
white blood cells characterized by the
presence of granules in their cytoplasm.[1]
They are also called polymorphonuclear
leukocytes (PMN or PML) because of the
varying shapes of the nucleus, which is
usually lobed into three segments.
 The myeloblast is a unipotent stem cell,
which will differentiate into one of the
8/12/2009 actors of the granular series. 11
Acute Myelogenous Leukemia
(AML)
 Leukemia characterized by proliferation of myeloid
tissue (as of the bone marrow and spleen) and an
abnormal increase in the number of granulocytes,
myelocytes, and myeloblasts in the circulating blood
 One fourth of all leukemias
– 85% of the acute leukemias in adults
 Abrupt, dramatic onset
– Serious infections, abnormal bleeding
 Uncontrolled proliferation of myeloblasts
– Hyperplasia of bone marrow and spleen

8/12/2009 12
Acute Lymphocytic Leukemia
(ALL)
 Most common type of leukemia in
children
 15% of acute leukemia in adults
 Immature lymphocytes proliferate in the
bone marrow

8/12/2009 13
Acute Lymphocytic Leukemia
 Signs and symptoms may appear
abruptly
– Fever, bleeding
 Insidious with progressive

– Weakness, fatigue
 Central nervous system manifestations

8/12/2009 14
Chronic Myelogenous Leukemia
(CML)
 Excessive development of mature
neoplastic granulocytes in the bone
marrow
– Move into the peripheral blood in
massive numbers
– Ultimately infiltrate the liver and
spleen

8/12/2009 15
Chronic Myelogenous Leukemia
 Philadelphia chromosome
– The chromosome abnormality that
causes chronic myeloid leukemia
(CML) (9 &22)
– Genetic marker
 Chronic, stable phase followed by acute,
aggressive (blastic) phase
8/12/2009 16
Chronic Lymphocytic Leukemia
(CLL)
 Production and accumulation of
functionally inactive but long-lived,
mature-appearing lymphocytes
 B cell involvement
 Lymph node enlargement is noticeable
throughout the body
– ↑ incidence of infection

8/12/2009 17
Chronic Lymphocytic Leukemia
 Complications from early-stage CLL is
rare
– May develop as the disease advances
– Pain, paralysis from enlarged lymph
nodes causing pressure

8/12/2009 18
Hairy Cell Leukemia
 2% of all adult leukemias
 Usually in males > 40 years old
 Chronic disease of lymphoproliferation

– B lymphocytes that infiltrate the bone

marrow and liver

8/12/2009 19
Hairy Cell Leukemia
 Cells have a “hairy” appearance
 Symptoms from
– Splenomegaly, pancytopenia, infection,
vasculitis
 Treatment
– alpha-interferon, pentostatin,
cladribine

8/12/2009 20
Unclassified Leukemias
 Subtype cannot be identified
 Malignant leukemic cells may have
– Lymphoid, myeloid, or mixed
characteristics
 Frequently these patients do not respond
well to treatment
– Poor prognosis

8/12/2009 21
Leukemia
Clinical Manifestations
 Relate to problems caused by
– Bone marrow failure
• Overcrowding by abnormal cells
• Inadequate production of normal marrow
elements
• Anemia, thrombocytopenia, ↓ number
and function of WBCs

8/12/2009 22
Leukemia
Clinical Manifestations
 Relate to problems caused by
– Leukemic cells infiltrate patient’s
organs
• Splenomegaly
• Hepatomegaly
• Lymphadenopathy
• Bone pain, meningeal irritation, oral
lesions (chloromas)

8/12/2009 23
Leukemia
Diagnostic Studies
 To diagnose and classify
– Peripheral blood evaluation (CBC and
blood smear)
– Bone marrow evaluation
 To identify cell subtype and stage

– Morphologic, histochemical,
immunologic, and cytogenic methods
8/12/2009 24
Leukemia
Collaborative Care
 Goal is to attain remission (when there is
no longer evidence of cancer cells in the
body)
 Chemotherapeutic treatment
– Induction therapy
• Attempt to induce or bring remission
• Seeks to destroy leukemic cells in the
tissues, peripheral blood, bone marrow
• Patient may become critically ill
– Provide psychological support as well
8/12/2009 25
What is remission?
The main aim of treatment for acute lymphoblastic leukaemia is to
give a remission. This means that the abnormal, immature white
cells or blasts can no longer be detected in your blood or bone
marrow, and normal bone marrow has developed again.
 However, once you are in remission there may still be a very small
number of abnormal lymphoblasts left. To destroy these, your
doctor may prescribe maintenance or continuation chemotherapy
which may last for several years. These drugs are mainly taken as
tablets and you will need to have regular check-ups to monitor
their effect. Very specialised blood tests to find particular proteins
present on the surface of the leukaemia cells can show if any
leukaemia cells are still present in the body.
 For many people with acute lymphoblastic leukaemia the
remission lasts indefinitely and the person is said to be cured.

8/12/2009 26
Leukemia
Collaborative Care
 Chemotherapeutic treatment (cont.)
– Intensification therapy
• High-dose therapy
• May be given after induction therapy
• Same drugs at higher doses and/or other
drugs

8/12/2009 27
Leukemia
Collaborative Care
 Chemotherapeutic treatment (cont.)
– Consolidation therapy
• Started after remission is achieved
• Purpose is to eliminate remaining
leukemic cells that may not be evident
– Maintenance therapy
• Lower doses of the same drug

8/12/2009 28
 Leukemia
Chemotherapy Regimens
 Combination chemotherapy
– Mainstay treatment
– 3 purposes
• ↓ drug resistance
• ↓ drug toxicity to the patient by using
multiple drugs with varying toxicities
• Interrupt cell growth at multiple points in
the cell cycle

8/12/2009 29
Leukemia - Bone Marrow and Stem
Cell Transplantation
 Goal
– Totally eliminate leukemic cells from
the body using combinations of
chemotherapy with or without total
body irradiation

8/12/2009 30
Leukemia - Bone Marrow and Stem
Cell Transplantation
 Eradicates patient’s hematopoietic stem cells
 Replaced with those of an HLA-matched
(Human Leukocyte Antigen)
• Sibling (is a brother or a sister; that is, any
person who shares at least one of the same
parents )
• Volunteer
• Identical twin
• Patient’s own stem cells removed before

8/12/2009 31
Nursing Management
Planning
 Overall goals
– Understand and cooperate with the
treatment plan
– Experience minimal side effects and
complications of disease and treatment
– Feel hopeful and supported during the
periods of treatment, relapse, and
remission
8/12/2009 32
Nursing Management
 Many physical and psychological needs
– Evokes great fear
• Family also needs help
 Balance demanding technical needs with
a humanistic, caring approach

8/12/2009 33
 Nursing Management
 Patient empowered by knowledge of the
disease and treatment can have a more
positive outlook and improved quality of
life
 Nurses face special challenges when
meeting the intense psychosocial needs of
a patient with leukemia

8/12/2009 34
Nursing Management
 Ongoing care is necessary to monitor for
signs and symptoms of disease control or
relapse
 Teach patient and significant other
– Diligence in disease management
– Need for follow-up care
– When to seek medical attention

8/12/2009 35
Nursing Management
 Goals of rehabilitation
– Manage
• Physical
• Psychosocial
• Social
• Spiritual
• Delayed effects
– Support groups
8/12/2009 36
Nursing Management
Evaluation
 Cope effectively with diagnosis,
treatment regimen, and prognosis
 Attain and maintain adequate nutrition
 Experience no complications
 Feel comfortable and supported

8/12/2009 37
 BEST WISHES

8/12/2009 38